Fingolimod ameliorates amyloid deposition and neurodegeneration in APP/PS1 mouse model of Alzheimer's disease
This study illustrates that fingolimod effectively ameliorates multiple pathological features of AD, highlighting its potential as a promising therapeutic candidate for the disease.
Authors
- Yan‐Jiang Wang (ORCID: https://orcid.org/0000-0002-6227-6112)
- Mengting Wang (ORCID: https://orcid.org/0000-0003-2153-6632)
- Zhang-Cheng Fei
- Zicheng Hu (ORCID: https://orcid.org/0000-0003-3747-232X)
- Xiaoqin Zeng (ORCID: https://orcid.org/0000-0003-3149-6320)
- Jia Chen (ORCID: https://orcid.org/0009-0002-9752-0354)
- Zhiqiang Xu (ORCID: https://orcid.org/0000-0001-7625-0426)
- Xinpeng Li (ORCID: https://orcid.org/0000-0003-1165-4723)
- Yang Xiang (ORCID: https://orcid.org/0000-0002-6971-0356)
- Y. C. Zhu (ORCID: https://orcid.org/0009-0003-7137-7876)
- Yu-Hui Liu (ORCID: https://orcid.org/0009-0004-7700-3522)
- Jun Wang (ORCID: https://orcid.org/0000-0003-0376-6071)
Institutions
- University of Electronic Science and Technology of China (CN)
- Army Medical University (CN)
- Daping Hospital (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- The Journal of Prevention of Alzheimer s Disease
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1016/j.tjpad.2025.100131
- Citations
- 1
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.16